FHTX
Price
$4.36
Change
-$0.17 (-3.75%)
Updated
Nov 13 closing price
Capitalization
246.56M
111 days until earnings call
Intraday BUY SELL Signals
XOMA
Price
$32.24
Change
-$1.38 (-4.10%)
Updated
Nov 13 closing price
Capitalization
399.23M
111 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

FHTX vs XOMA

Header iconFHTX vs XOMA Comparison
Open Charts FHTX vs XOMABanner chart's image
Foghorn Therapeutics
Price$4.36
Change-$0.17 (-3.75%)
Volume$189.79K
Capitalization246.56M
XOMA Royalty
Price$32.24
Change-$1.38 (-4.10%)
Volume$48.69K
Capitalization399.23M
FHTX vs XOMA Comparison Chart in %
FHTX
Daily Signal:
Gain/Loss:
XOMA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
FHTX vs. XOMA commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FHTX is a Hold and XOMA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (FHTX: $4.53 vs. XOMA: $33.62)
Brand notoriety: FHTX and XOMA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FHTX: 78% vs. XOMA: 118%
Market capitalization -- FHTX: $246.56M vs. XOMA: $399.23M
FHTX [@Biotechnology] is valued at $246.56M. XOMA’s [@Biotechnology] market capitalization is $399.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FHTX’s FA Score shows that 0 FA rating(s) are green whileXOMA’s FA Score has 1 green FA rating(s).

  • FHTX’s FA Score: 0 green, 5 red.
  • XOMA’s FA Score: 1 green, 4 red.
According to our system of comparison, XOMA is a better buy in the long-term than FHTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FHTX’s TA Score shows that 5 TA indicator(s) are bullish while XOMA’s TA Score has 4 bullish TA indicator(s).

  • FHTX’s TA Score: 5 bullish, 4 bearish.
  • XOMA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, FHTX is a better buy in the short-term than XOMA.

Price Growth

FHTX (@Biotechnology) experienced а +13.25% price change this week, while XOMA (@Biotechnology) price change was +0.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

FHTX is expected to report earnings on Mar 05, 2026.

XOMA is expected to report earnings on Mar 05, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XOMA($399M) has a higher market cap than FHTX($247M). XOMA YTD gains are higher at: 27.930 vs. FHTX (-4.025). XOMA has higher annual earnings (EBITDA): -305K vs. FHTX (-88.7M). FHTX has more cash in the bank: 199M vs. XOMA (83.9M). FHTX has less debt than XOMA: FHTX (23.7M) vs XOMA (115M). FHTX has higher revenues than XOMA: FHTX (24.2M) vs XOMA (12.8M).
FHTXXOMAFHTX / XOMA
Capitalization247M399M62%
EBITDA-88.7M-305K29,080%
Gain YTD-4.02527.930-14%
P/E RatioN/AN/A-
Revenue24.2M12.8M189%
Total Cash199M83.9M237%
Total Debt23.7M115M21%
FUNDAMENTALS RATINGS
XOMA: Fundamental Ratings
XOMA
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
PROFIT vs RISK RATING
1..100
71
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FHTXXOMA
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 10 days ago
86%
Bearish Trend 17 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
FHTX
Daily Signal:
Gain/Loss:
XOMA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BGEWX12.230.05
+0.41%
Baillie Gifford Emer Mkt Ex Chn Instl
SIVIX17.080.02
+0.12%
State Street Instl Small-Cap Equity Inv
ECSMX10.550.01
+0.09%
Eaton Vance Small-Cap C
JGLTX24.39-0.01
-0.04%
Janus Henderson VIT Glb Tech&Innvt Instl
PCAOX90.54-0.13
-0.14%
Principal Capital Appreciation R3

FHTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, FHTX has been loosely correlated with OCUL. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if FHTX jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FHTX
1D Price
Change %
FHTX100%
+2.03%
OCUL - FHTX
46%
Loosely correlated
+2.41%
NRIX - FHTX
45%
Loosely correlated
-5.37%
ERAS - FHTX
44%
Loosely correlated
+12.29%
MGNX - FHTX
43%
Loosely correlated
-3.29%
IPSC - FHTX
41%
Loosely correlated
N/A
More

XOMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, XOMA has been loosely correlated with SYRE. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if XOMA jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XOMA
1D Price
Change %
XOMA100%
-2.52%
SYRE - XOMA
42%
Loosely correlated
+0.34%
BDTX - XOMA
40%
Loosely correlated
+5.41%
FENC - XOMA
40%
Loosely correlated
-1.77%
ARWR - XOMA
38%
Loosely correlated
-0.19%
FHTX - XOMA
38%
Loosely correlated
+2.03%
More